PLEASE NOTE ALL AGENDA TIMES, SPEAKERS AND TOPICS ARE SUBJECT TO CHANGE UNTIL FINAL AGENDA IS CONFIRMED

Conference Agenda

 

  Go
  • Tuesday, March 3, 2020
  •  

    Registration

    7:00 AM  -  8:00 AM
    Primary Care Conference Registration
     

    Primary Care Conference

    8:00 AM  -  9:00 AM
    Keynote: Yoga Capsules for Self Care
    Health is the experience of physical, mental, emotional, social and spiritual well-being. Nurse practitioners and other healthcare professionals across the globe use yoga as a tool for valuable self-care, as well as in their practice settings. Yoga can be safe, science-smart, effective, affordable and therapeutic, depending upon the application. Jay Gupta, a pharmacist and yoga therapist, will discuss the potential ways that yoga might act like a medicine and be positioned as the next blockbuster drug.
    9:15 AM  -  10:15 AM
    A1: Vaping Update
    The use of electronic cigarettes has rapidly risen over the past 20 years even as smoking cessation efforts have been largely successful. Since the summer of 2019, there have been many reports of e-cigarette related deaths. This is a fast-moving topic with new information from a public health, clinical and public policy perspective. E-cigarette, or vaping, product use associated lung injury (EVALI) is a new diagnosis that describes patients afflicted with this life threatening critical illness. This session will review epidemiology, pathophysiology and up-to-date knowledge on vaping related injury with a special emphasis on how to counsel patients about risks of vaping.
    Speakers:
    10:25 AM  -  11:25 AM
    B1: Polypharmacy, Deprescription and Older Adults
    We live in a drug culture with pills for every ill, and ills for every pill. This has resulted in an unprecedented experience of polypharmacy, where prescribing essentially continues to be a one-way street, despite our best efforts with medication reviews. Taking the medicine away is not the acceptable solution. What is? This session considers polypharmacy and deprescription in the older adult population.
    11:25 AM  -  12:45 PM
    Lunch on Own
    12:45 PM  -  1:45 PM
    C1: Asthma: From the Basics to the Biologics
    Most patients with asthma are managed by primary care providers and not by specialists. This session will summarize the advances in the evaluation and management of asthma from basics to biologics using updated 2019 GINA guidelines. Treatment of difficult asthma, especially severe asthma and asthma/COPD overlap will be discussed. Use of personalized medicine with biologics and new drugs in development for asthma will be reviewed. The challenges of delivering healthcare in rural and other environments with lower access to resources will be incorporated in all treatment approaches.
    Speakers:
    1:55 PM  -  2:55 PM
    D1: Common GI Complaints
     
    4:30 PM  -  7:30 PM
    Psoriasis Dinner Program

    In conjunction with the National Psoriasis Foundation this Psoriasis Recognition Program is designed to help enhance your skills in caring for those with psoriasis. After completing this program, attendees will be formally recognized as up-to-date in the latest psoriasis education.

    This activity is supported by educational grants from Bristol-Myers Squibb and Janssen. 

    The National Psoriasis Foundation designates this live activity for a maximum of 3.0 AMA PRA Category 1 CreditsTM 

     

    Click here to register for this program

  • Wednesday, March 4, 2020
  •  

    Primary Care Conference

    7:00 AM  -  8:00 AM
    BR1: Influenza Treatment in the Primary Care Setting

    By completing this session, participants will be able to apply new evidence into practice regarding the use of diagnostic testing, treatment and chemoprophylaxis for people with, or at risk for, influenza. Also, Incorporate the use of antiviral agents into practice based on their ability to reduce transmission, as well as treat people with influenza who are at normal or high risk for complications.

    Content Developed by: John J. Russell, MD, Clinical Professor of Family and Community Medicine,Thomas Jefferson University Sidney Kimmel School of Medicine, Philadelphia, PA; Chair, Department of Family Medicine and Program Director, Family Medicine Residency, Abington – Jefferson Health, Abington, PA

    This activity is supported by an educational grant from Genentech, Inc.
    This continuing nurse education activity is provided by Vindico Medical Education.

    8:15 AM  -  9:15 AM
    E1: Person 1st Patient Care: Merging Evidence with Individualized Care Objectives
    9:15 AM  -  9:45 AM
    Exhibit Hall Grand Opening
    9:45 AM  -  10:45 AM
    F1: Workup of Abnormal Liver Function Tests
    10:55 AM  -  11:55 AM
    G1: Diagnosis and Management of Hydradenitis Suppuritiva
    11:55 AM  -  12:30 PM
    Sign in with Sponsor for Product Theater
    12:30 PM  -  1:30 PM
    LP1: NON-CE Product Theater Lunch Session
    When is the Right Time to Start a GLP-1 RA in Adult Patients with T2D?

    This session is provided by a commercial interest. Contact Hours will not be awarded.

    1:45 PM  -  2:45 PM
    H1: Pain Management and Opioids: Balancing Risks and Benefits: Part 1

    Sponsored by the Nurse Practitioner Healthcare Foundation, this newly updated session addresses: nature and pathophysiology of pain; assessing patients in pain and creating a treatment plan; non-pharmacologic pain treatment strategies; initiating and managing patients on opioid therapy; educating patients and caregivers; and understanding opioid use disorder. Fully compliant with the September 2018 FDA Blueprint for Opioid REMS Education, this session meets many states’ requirements for controlled substances CE.

    The curriculum is developed by the Collaborative for REMS Education (CO*RE) http://core-rems.org and supported by an independent educational grant from the Opioid Analgesic REMS Program Companies (RPC).

    3:15 PM  -  4:15 PM
    I1: Pain Management and Opioids: Balancing Risks and Benefits: Part 2

    Sponsored by the Nurse Practitioner Healthcare Foundation, this newly updated session addresses: nature and pathophysiology of pain; assessing patients in pain and creating a treatment plan; non-pharmacologic pain treatment strategies; initiating and managing patients on opioid therapy; educating patients and caregivers; and understanding opioid use disorder. Fully compliant with the September 2018 FDA Blueprint for Opioid REMS Education, this session meets many states’ requirements for controlled substances CE.

    The curriculum is developed by the Collaborative for REMS Education (CO*RE) http://core-rems.org and supported by an independent educational grant from the Opioid Analgesic REMS Program Companies (RPC).

  • Thursday, March 5, 2020
  •  

    Registration

    7:00 AM  -  8:00 AM
    Pharmacology Conference Registration
     

    Pharmacology Conference

    8:00 AM  -  9:30 AM
    PH1: Hyperlipidemia Pharmacotherapeutics
    10:00 AM  -  11:30 AM
    PH2: Diabetes Pharmacotherapeutics
    11:30 AM  -  12:00 PM
    Sign in with Sponsor for Product Theater
    12:00 PM  -  1:00 PM
    PH-LP1: NON-CE Product Theater Lunch Session

    Case Study: A 51-year-old female with Crohn’s disease and intestinal resection 

    This session is provided by a commercial interest. Contact Hours will not be awarded.

    1:15 PM  -  2:45 PM
    PH3: Antimicrobial Stewardship, Trends of Antimicrobial Resistance, and Future Implications
    This presentation will provide an overview of the efforts and progress of antimicrobial stewardship initiatives and implications on current and future practice. This overview will include current progress and limitations of the current regulatory landscape for new antimicrobial approval and development.
    3:00 PM  -  4:30 PM
    PH4: Updates on Treatment of Skin Infection, UTI and STI
    This presentation will address updates in the management of each of the disease states, including recent data on epidemiology and outcomes, treatment recommendations and practice controversies. The presentation will also summarize how antimicrobial stewardship plays a role in the management of each disease state.
  • Friday, March 6, 2020
  •  

    Pharmacology Conference

    8:00 AM  -  9:30 AM
    PH5: Therapeutics Updates: Respiratory Infections
    9:45 AM  -  11:15 AM
    PH6: Therapeutics Updates: Vaccinations in the Ambulatory Setting
    11:15 AM  -  11:45 AM
    Sign in with Sponsor for Product Theater
    11:45 AM  -  12:45 PM
    PH-LP2: NON-CE Product Theater Lunch Session

    Renal and Cardiovascular Outcomes in Patients With Diabetic Nephropathy (ie, Diabetic Kidney Disease) and Type 2 Diabetes

    This session is provided by a commercial interest. Contact Hours will not be awarded.

    1:00 PM  -  2:30 PM
    PH7: Cardiovascular Pharmacotherapeutics: Part 1
    2:40 PM  -  4:10 PM
    PH8: Cardiovascular Pharmacotherapeutics: Part 2
Top